IP Library Patent Application 14256716
Patent Application
App. No. 14/256,716

ANALYTE SENSOR

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/256,716
Abstract

Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into a host's peripheral vein or artery.

Claims (12)

1 . A system for measuring glucose in a host and delivering medication to the host, the system comprising:

a catheter configured for insertion into a host and configured to deliver medication to the host, wherein the catheter comprises an exterior surface;

a continuous glucose sensor disposed at least partially on the exterior surface of the catheter, wherein the continuous glucose sensor is configured to generate sensor data indicative of glucose concentration; and

sensor electronics operatively connected to the continuous glucose sensor, wherein the sensor electronics are configured to determine a glucose concentration.

2 . The system of claim 1 , wherein the continuous glucose sensor is integrally formed on the exterior surface of the catheter.

3 . The system of claim 1 , wherein the continuous glucose sensor is electroplated onto the exterior surface of the catheter.

4 . The system of claim 1 , wherein the continuous glucose sensor comprises a working electrode and a membrane system covering at least a portion of the working electrode.

5 . The system of claim 1 , wherein the working electrode comprises an exposed electroactive surface.

6 . The system of claim 1 , wherein the catheter is configured to be operatively connected to an infusion pump.

7 . The system of claim 1 , wherein in response to sensor data received from the continuous glucose sensor, the sensor electronics are configured to communicate a therapy recommendation to the infusion pump, wherein the therapy recommendation comprises information relating to insulin amount.

8 . The system of claim 1 , wherein the continuous glucose sensor is configured to be used subcutaneously.

9 . The system of claim 1 , wherein the sensor electronics are configured to substantially continuously determine the glucose concentration.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2014
From: BRISTER, MARK; SAINT, SEAN; SWANSON, VANCE; QUINTANA, NELSON
To: DEXCOM, INC.
Reel/Frame 032872/0761 →